Delivery Order SPE2DB20D2104-SPE2DB25FMVPG
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EMVERM 100 MG TABLET CHEW UDS. The delivery order has a ceiling value of $70,229.59 and is a Firm Fixed Price contract. The contract has an ultimate completion date of September 26, 2024. AmerisourceBergen, through its Corporate Office Division, will be responsible for delivering these pharmaceutical products to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.24 firm-fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,747.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with a period of performance through May 1, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,383.49, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,074.41, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 3, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a for-profit organization...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4557841419 EMVERM 100 MG TABLET CHEW UDS. The $3,546.70 firm fixed price Delivery Order has a completion date of July 20, 2022 and was awarded on July 19, 2022. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of EMVERM 100 MG TABLET CHEW UDS. The order, valued at $33,296.99, is a firm fixed-price contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EMVERM 100 MG TABLET CHEW medical supplies. The contract, valued at $24,685.31, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 19, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $6,827.21. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS medication, and is a firm fixed-price contract with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned....
- This is a $13,987.95 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of EMVERM 100 MG TABLET CHEW UDS medical products. The contract has an ultimate completion date of June 4, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVPGDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product, with a ceiling value of $2,124.68. The contract is a firm fixed price delivery order, non-set-aside, with a completion date of July 17, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/16/25 |